Identification of a Five-Gene Panel to Assess Prognosis for Gastric Cancer.

The patients who have mutations in these five genes may experience longer survival than those who do not have mutations. This five-gene panel will likely be a practical tool for prognostic evaluation and will provide another possible way for clinicians to determine therapy.